Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Colorectal Neoplasms and UGT1A7[original query] |
|---|
| Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 2002 Jun 50 (6): 851-6. Strassburg C P, Vogel A, Kneip S, Tukey R H, Manns M |
| Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 2004 Dec 25 (12): 2407-15. van der Logt E M J, Bergevoet S M, Roelofs H M J, van Hooijdonk Z, te Morsche R H M, Wobbes T, de Kok J B, Nagengast F M, Peters W H |
| Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes. World journal of gastroenterology : WJG 2005 Jun 11 (21): 3250-4. Tang Kung-Sheng, Chiu Hui-Fen, Chen Hong-Hwa, Eng Hock-Liew, Tsai Chia-Jung, Teng Hsiu-Chen, Huang Ching-Sh |
| UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. Clinical cancer research : an official journal of the American Association for Cancer Research 2005 Feb 11 (3): 1226-36. Carlini Leslie E, Meropol Neal J, Bever John, Andria Michael L, Hill Todd, Gold Philip, Rogatko Andre, Wang Hao, Blanchard Rebecca |
| Polymorphisms of uridine-diphosphoglucuronosyltransferase 1A7 gene in Taiwan Chinese. World journal of gastroenterology : WJG 2005 Feb 11 (6): 797-802. Huang May-Jen, Yang Sien-Sing, Lin Min-Shung, Huang Ching-Sh |
| Genetic polymorphisms of the uridine diphosphate glucuronosyltransferase 1A7 and colorectal cancer risk in relation to cigarette smoking and alcohol drinking in a Chinese population. Journal of gastroenterology and hepatology 2006 Jun 21 (6): 1036-41. Chen Kun, Jin Mingjuan, Zhu Yimin, Jiang Qinting, Yu Weiping, Ma Xinyuan, Yao Kaiy |
| [Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer]. Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine] 2006 Jan 40 (1): 13-7. Fan Chun-hong, Jin Ming-juan, Zhang Yang, Song Liang, Xu Hong, Jiang Qin-ting, Yu Wei-ping, Chen K |
| Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Mar 17 (3): 695-701. Lankisch Tim O, Schulz Christoph, Zwingers Thomas, Erichsen Thomas J, Manns Michael P, Heinemann Volker, Strassburg Christian |
| Predictive role of the UGT1A1, UGT1A7, and UGT1A9 genetic variants and their haplotypes on the outcome of metastatic colorectal cancer patients treated with fluorouracil, leucovorin, and irinotecan. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 May 27 (15): 2457-65. Cecchin Erika, Innocenti Federico, D'Andrea Mario, Corona Giuseppe, De Mattia Elena, Biason Paola, Buonadonna Angela, Toffoli Giusep |
| UGT1A and TYMS genetic variants predict toxicity and response of colorectal cancer patients treated with first-line irinotecan and fluorouracil combination therapy. British journal of cancer 2010 Aug 103 (4): 581-9. Martinez-Balibrea E, Abad A, Martínez-Cardús A, Ginés A, Valladares M, Navarro M, Aranda E, Marcuello E, Benavides M, Massutí B, Carrato A, Layos L, Manzano J L, Moreno |
| Genetic polymorphisms of UGT1A7 and cancer risk: evidence from 21 case-control studies. Cancer investigation 2011 Dec 29 (10): 645-54. Lu Pei-Hua, Chen Min-Bin, Wu Xiao-Yang, Gu Jin-Hua, Liu Yuan, Gu Rong-M |
| Association between polymorphisms in UDP-glucuronosyltransferase 1A6 and 1A7 and colorectal cancer risk. Asian Pacific journal of cancer prevention : APJCP 2012 13 (5): 2311-4. Osawa Kayo, Nakarai Chiaki, Akiyama Minami, Hashimoto Ryuta, Tsutou Akimitsu, Takahashi Juro, Takaoka Yuko, Kawamura Shiro, Shimada Etsuji, Tanaka Kenichi, Kozuka Masaya, Yamamoto Masahiro, Kido Yoshia |
| Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk. International journal of molecular epidemiology and genetics 2012 3 (2): 96-106. Eichholzer Monika, Rohrmann Sabine, Barbir Aline, Hermann Silke, Teucher Birgit, Kaaks Rudolf, Linseisen Jak |
| UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. Cancer science 2013 Dec 104 (12): 1662-9. Hazama Shoichi, Mishima Hideyuki, Tsunedomi Ryouichi, Okuyama Yusuke, Kato Takeshi, Takahashi Ken-ichi, Nozawa Hiroshi, Ando Hideaki, Kobayashi Michiya, Takemoto Hiroyoshi, Nagata Naoki, Kanekiyo Shinsuke, Inoue Yuka, Hamamoto Yoshihiko, Fujita Yusuke, Hinoda Yuji, Okayama Naoko, Oba Koji, Sakamoto Jun-ichi, Oka Masaa |
| S-1 plus irinotecan and oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: a prospective phase II study and pharmacogenetic analysis. British journal of cancer 2013 Sep 109 (6): 1420-7. Kim S Y, S Hong Y, K Shim E, Kong S-Y, Shin A, Baek J Y, Jung K |
| Polymorphic expression of UDP-glucuronosyltransferase UGTlA gene in human colorectal cancer. PloS one 2013 8 (2): e57045. Wang Min, Sun De-Feng, Wang Shuai, Qing Ying, Chen Shuo, Wu Dong, Lin Ying-Min, Luo Ji-Zhuang, Li Yan-Qi |
| A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes. International journal of oncology 2014 Oct 45 (4): 1381-90. Tsunedomi Ryouichi, Hazama Shoichi, Fujita Yusuke, Okayama Naoko, Kanekiyo Shinsuke, Inoue Yuka, Yoshino Shigefumi, Yamasaki Takahiro, Suehiro Yutaka, Oba Koji, Mishima Hideyuki, Sakamoto Junichi, Hamamoto Yoshihiko, Oka Masaa |
| XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer. Oncology letters 2014 Oct 8 (4): 1864-1872. Cui Chengxu, Shu Chang, Yang Yi, Liu Junbao, Shi Shuping, Shao Zhujun, Wang Nan, Yang Ting, Hu Songni |
| Examination of multiple UGT1A and DPYD polymorphisms has limited ability to predict the toxicity and efficacy of metastatic colorectal cancer treated with irinotecan-based chemotherapy: a retrospective analysis. BMC cancer 2017 Jun 17 (1): 437. Liu Dan, Li Jian, Gao Jing, Li Yanyan, Yang Rui, Shen L |
| Effect of UGT, SLCO, ABCB and ABCC polymorphisms on irinotecan toxicity. Medicina clinica 2018 Feb . García Gil Sara, Ramos Díaz Ruth, Nazco Casariego Gloria Julia, Llanos Muñoz Marta, Viña Romero Maria Micaela, Martín Calero Braulio, Pérez Pérez Jose Antonio, Gutiérrez Nicolás Fernan |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: